Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when XMAX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsXMax raises $31.1M in private placement, diluting shares by 13.4%
Filed April 29, 2026 · Period ending April 24, 2026 · ~1 min read
Key Changes
-
high
XMax sold 8.55 million common shares at $3.64 per share to six non-U.S. investors, raising $31.1 million in cash. This represents approximately 13.4% dilution to existing shareholders based on the post-transaction share count of 63.6 million.
Item 1.01 verify on EDGAR → -
medium
The offering was conducted under Regulation S, which exempts securities sold to non-U.S. persons from SEC registration. These shares may have resale restrictions that could affect future trading liquidity.
Item 3.02 verify on EDGAR → -
medium
Total issued common stock now stands at 63.6 million shares as of April 29, 2026, providing the current fully diluted share count for valuation purposes.
Item 1.01 verify on EDGAR →
Summary
XMax Inc. completed a $31.1 million private placement on April 24, 2026, selling 8.55 million common shares at $3.64 per share to six non-U.S. investors. The transaction dilutes existing shareholders by approximately 13.4%, bringing total issued shares to 63.6 million. The company used Regulation S, which allows sales to foreign investors without SEC registration but may impose resale restrictions.
Retail investors should note the immediate dilution impact on their ownership percentage and earnings per share. The $3.64 price point provides a reference for recent institutional valuation. The capital infusion suggests XMax needed funding, though the 8-K doesn't disclose the intended use of proceeds.
Watch for the next quarterly filing (10-Q) to see how management deployed this capital and whether the company provides guidance on runway or growth initiatives. Also monitor whether these shares hit the market after any lock-up period expires, which could create selling pressure.
Section-by-Section Diff
Event · Item 3.02 — Unregistered Sales of Equity Securities
8-K references unregistered equity sales disclosed under Item 1.01, but Item 1.01 text is not provided in this filing excerpt.
Added in current filing · verify on EDGAR →
Item 3.02 Unregistered Sales of Equity Securities Please see the disclosure set forth under Item 1.01, which is incorporated by reference into this Item 3.02.
The company disclosed unregistered sales of equity securities under Item 3.02, with details cross-referenced to Item 1.01. Without the Item 1.01 text, the specific terms, purchasers, amounts, and exemptions relied upon cannot be determined from this excerpt.
Event · Item 9.01 — Financial Statements and Exhibits
XMax Inc. entered into Securities Purchase Agreements with purchasers on April 24, 2026.
Added in current filing · verify on EDGAR →
Form of Securities Purchase Agreements by and between the Company and Purchasers dated April 24, 2026.
XMax Inc. executed Securities Purchase Agreements with purchasers on April 24, 2026. The 8-K does not disclose the terms, amount raised, securities issued, or identity of purchasers — those details would be in the attached exhibit. This typically indicates a capital raise through private placement or similar financing transaction.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify